16729-108 : Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC16729-108
Labeler: Accord Healthcare Inc
Product Type: Human Prescription Drug
Drug Name:  Mitomycin
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA064144
Rev. Date: 


NDC Package Codes:

  • 16729-108-11: 1 VIAL IN 1 BOX, UNIT‑DOSE (16729‑108‑11) > 40 ML IN 1 VIAL

Active Ingredients:

  • Mitomycin

Dosage Strength:

  • 20 mg/40mL

Pharmaceutical Classes:

  • Alkylating Activity [MoA]
  • Alkylating Drug [EPC]

Related Products:

Based on records with the same trade name.
  • 16729-115 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 16729-116 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 16729-246 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 16729-247 Mitomycin 20 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 16729-248 Mitomycin 40 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc
  • 0143-9279 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 0143-9280 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 67457-518 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 67457-519 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 67457-520 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 68001-389 Mitomycin 5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-390 Mitomycin 20 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-391 Mitomycin 40 mg/80ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 16729-108 QR Code

< Prev: 16729-097Next: 16729-109 >

Related Discussions:

bcg vs. mitomycin
treatment with mitomycin on bladder cancer was not tolerated. physician wishes to treat now with BCG. Comments?...
material safety data sheet-mitomycin
mitomycin ## Here's the site for that product with such information for you: Material Safety Data Mitomycin Click He... 2 replies




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA